Display options
Share it on

Surg Technol Int. 1993 Oct;2:255-8.

High speed rotational atherectomy in coronary artery disease.

Surgical technology international

P K Raju, S H Stertzer, R E Shaw, E Pomerantsev, R Zipkin, R K Myler, M Murphy

Affiliations

  1. San Francisco Heart Institute, Seton Medical Center, Daly City, California.

PMID: 25951572

Abstract

Despite major advances in its diagnosis and management, coronary artery disease remains the major cause of death accounting for 45.3 percent of all deaths in the United States. One of the major milestones in the treatment of coronary artery disease has been the introduction of non-surgical revascularization in the form of percutaneous transluminal coronary angioplasty by Andreas Gmentzig in 1977. In the early years, PTCA could only be performed in proximal, discrete, non-calcified lesions. Over the last decade, major advances in the catheter, balloon and guide wire technology as well as increased operator experience extended the benefits of PTCA to patients with more complex lesions and multivessel coronary artery disease. Although the initial impetus for the development of newer devices has been to address the problem of restenosis, they are proving to be useful in treating lesions that are inadequately treated or subject to increased incidence of complications. The high speed rotational atherectomy is a valuable addition with its ability to treat long, calcified lesions. This report will describe the technical aspects of the Rotablator®, the procedure of high speed rotational atherectomy and its clinical applications.

Publication Types